Identification of Anaplasma phagocytophilum and Borrelia burgdorferi sensu lato in patients with erythema migrans

Folia Microbiologica

Volumn 54, Issue 3, 2009, Pages 246-256

  Hulinska D ^a   Votypka J ^a   Vanousova D ^b   Hercogova J ^b   Hulinsky V ^c   Drevova H ^a   Kurzova Z ^a   Uherkova L ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^b UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

^c Regional Hospital Nymburk   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; BACTERIUM ANTIBODY; LIPOPROTEIN; MEMBRANE ANTIGEN; OUTER MEMBRANE PROTEIN; OUTER SURFACE PROTEIN A;

ADOLESCENT; ADULT; AGED; ANAPLASMA PHAGOCYTOPHILUM; ARTICLE; BLOOD; BORRELIA BURGDORFERI; CELL STRAIN HL 60; DIFFERENTIAL DIAGNOSIS; EHRLICHIOSIS; ERYTHEMA CHRONICUM MIGRANS; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LYME DISEASE; MALE; MICROBIOLOGY; MIDDLE AGED; PLACENTA; PREGNANCY; PREGNANCY COMPLICATION;

ADOLESCENT; ADULT; AGED; ANAPLASMA PHAGOCYTOPHILUM; ANTIBODIES, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI; DIAGNOSIS, DIFFERENTIAL; EHRLICHIOSIS; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HL-60 CELLS; HUMANS; LIPOPROTEINS; LYME DISEASE; MALE; MIDDLE AGED; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

ANAPLASMA; ANAPLASMA PHAGOCYTOPHILUM; BORRELIA; BORRELIA AFZELII; BORRELIA BISSETTII; BORRELIA BURGDORFERI; BORRELIA BURGDORFERI GROUP; BORRELIA GARINII; BORRELIA VALAISIANA;

EID: 70349850942     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12223-009-0039-0     Document Type: Article

References (41)

1. Berger B.W., Johnson R.C., Kodner C., Coleman L.: Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J.Clin.Microbiol.30, 359-361 (1992).
2. Borjesson D.I.: Culture, isolation, and labeling of Anaplasma phagocytophilum for subsequent infection of human neutrophils, pp. 158-170 in Methods in Molecular Biology 431: Bacterial pathogenesis (F. DeLeo, M. Otto, Eds). Humana Press, Totowa (USA) 2008.
3. Casau N.C., Hewins M.E., Zaleznik D.F.: Treatment of human granulocytic ehrlichiosis during pregnancy and risk of perinatal transmission. Scan.J.Infect.Dis.34, 853-856 (2002).
4. Chen S.M., Dumler J.S., Bakken J.S., Walker D.H.: Identification of a granulocytic Ehrlichia species as the etiologic agent of human disease. J.Clin.Microbiol.32, 589-595 (1994).
5. Christova I.S., Dumler J.S.: Human granulocytic ehrlichiosis in Bulgaria. Am.J.Trop.Med.Hyg.60, 58-61 (1999).
6. Christova I., Schouls L., van de Pol I., Park J., Panayotov S., Lefterova V., Kantardjiev T., Dumler J.S.: High prevalence of granulocytic Ehrlichiae and Borrelia burgdorferi sensu lato in Ixodes ricinus ticks from Bulgaria. J.Clin.Microbiol.39,4172-4174 (2001).
7. Coulter P., Lema C., Flyhart D., Linhardt A.S., Aucott J.N., Auwaerter P.G., Dumler S.: Two years evaluation of Borrelia burgdorferi culture and supplemental tests for definitive diagnosis of Lyme disease. J.Clin.Microbiol.43, 5080-5084 (2005).
8. Courtney J.W., Kostelnik L.M., Zeidner N.S., Massung R.F.: Multiplex real-time PCR for detection of Anaplasma phagocytophilum and Borrelia burgdorferi. J.Clin.Microbiol.42, 3164-3168 (2004).
9. Dhand A, Nadelman R.B., Aguero-Rosenfeld M., Haddad F.A., Stokem D.P., Horowitz H.W.: Human granulocytic anaplasmosis during pregnancy: case series and literature review. Clin.Infect.Dis.45, 589-593 (2007).
10. Dumler J.S., Dotevall L., Gustavson R., Granstrom M.: A population-based seroepidemiologic study of human granulocytic ehrlichiosis and Lyme borreliosis on the West coast of Sweden. J.Infect.Dis.175, 720-722 (1997).
11. Goodman J.L., Nelson C., Vitale B., Madigan J.E., Dumler J.S., Kurtti T.J., Munderloh U.G.: Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N.Engl.J.Med.334, 209-215 (1996).
12. Gooskens J., Templeton K.E., Claas E.C., van Dam A.P.: Evaluation of an internally controlled real-time PCR targeting the OspA gene for detection of Borrelia burgdorferi sensu lato in cerebrospinal fluid. Clin.Microbiol.Infect.12, 894-900 (2006).
13. Harrus S., Waner T., Aizenberg I., Foley J.E., Poland A.M., Bark H.: Amplification of Ehrlichia DNA from dogs 34 month after infection with Ehrlichia canis. J.Clin.Microbiol.36, 73-76 (1998).
14. Herron M.J., Ericson M.E., Kurtti T.J., Munderloh U.G.: The interaction of Anaplasma phagocytophilum, endothelial cells, and human neutrophils. Ann.N.Y.Acad.Sci.1063, 374-382 (2008).
15. Horowitz H.W., Kilchevsky E., Haber S.: Perinatal transmission of the agent of human granulocytic ehrlichiosis. N.Engl.J.Med.339, 375-378 (1998).
16. Hulínská D., Votýpka J., Valešová M.: Persistence of Borrelia garinii and Borrelia afzelii in patients with Lyme arthritis. Zbl.Bacteriol.28, 301-313 (1999).
17. Hulínská D., Votýpka J., Plch J., Valešová M., Bojar M., Hulínský V.: Molecular and microscopical evidence of Ehrlichia sp. and Borrelia burgdorferi sensu lato in patiens, animals and ticks in the Czech Republic. New Microbiologica25, 437-448 (2002).
18. Hulínská D., Langrová K., Pejcoch M., Pavlásek I.: Detection of Anaplasma phagocytophilum in animals by real-time polymerase chain reaction. Acta.Pathol.Immunol.Scand.112, 239-247 (2004).
19. Hulínská D., Bojar M., Hulínský V.: Characterization of Borrelia burgdorferi sensu lato from Czech patients and ticks by culture and PCR sequence analysis, pp. 208-220 in F.C. Cabello, D. HulÍnská, H.P. Godfrey (Eds): Molecular Biology of Spirochetes. NATO ASI, Ser. I. Life and Behavior Sciences. IOS Press, Washington (DC, USA) 2006.
20. Hulínská D., Votýpka J., Kříž B., Holínková N., Nováková J., Hulínský V.: Phenotypic and genotypic analysis of Borrelia spp. isolated from Ixodes ricinus ticks by using electrophoretic chips and real-time polymerase chain reaction. Folia Microbiol.52, 315-324 (2007).
21. Ivacic L., Reed K.D., Mitchell P.D., Ghebranious N.A.: LightCycler TaqMan Assay for detection of Borrelia burgdorferi sensu lato in clinical samples. Diagn.Microbiol.Infect.Dis.57, 137-143 (2007).
22. Karlsson U., Bjoersdorff A., Massung R.F., Cristensson B.: Human granulocytic ehrlichiosis - a clinical case in Scandinavia. Scand.J.Infect.Dis.33, 73-75 (2001).
23. Kolbert C.: Detection of the agent of human granulocytic ehrlichiosis by PCR, pp. 106-111 in D. Persing (Ed.): PCR Protocols for Emerging Infectious Disease. ASM Press, Washington (DC, USA) 1996.
24. Levin M.L., Fish D.: Interference between the agent of Lyme disease and human granulocytic ehrlichiosis in a natural reservoir host. Vector-Borne Zoon.Dis.1, 139-147 (2001).
25. Loebermann M., Fingerle V., Lademann M., Fritzsche C., Reisinger E.C.: Borrelia burgdorferi and Anaplasma phagocytophilum coinfection. Emerg.Infect.Dis.12, 353-355 (2006).
26. Massung R.F., Slater K.G.: Comparison of PCR assays for detection of the agent of human granulocytic ehrlichiosis, Anaplasma phagocytophilum. J.Clin.Microbiol.41, 717-722 (2003).
27. Munderloh U.G., Madigan J.E., Dumlej J.S., Goodman J.L., Hayes S.F., Barlough J.E., Nelson C.M., Kurati T.J.: Isolation of the equine granulocytic ehrlichiosis agent, Ehrlichia equi, in tick cell culture. J.Clin.Microbiol.34, 664-670 (1996).
28. Nadelman R.B., Horowitz H.W., Hsien T.C., Wu J.M., Aguero-Rosenfeld J.M., Schwartz I., Nowakowski J., Varde S., Wormser G.P.: Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N.Engl.J.Med.337, 27-30 (1997).
29. Oksi J., Marjamaki M., Nikoskelainen J., Viljanen M.K.: Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis. Ann.Med.31, 225-232 (1999).
30. Ornstein K., Berglund J., Nilsson I., Norrby R., Bergstrom S.: Characterization of Lyme borreliosis isolates from patients with erythema migrans and neuroborreliosis in south Sweden. J.Clin.Microbiol.39, 1294-1298 (2001).
31. Pahl A., Kuhlbrandt U., Brune K., Rollinghoff M., Gessner A.: Quantitative detection of Borrelia burgdorferi by real-time PCR. J.Clin.Microbiol.37, 1958-1963 (1999).
32. Parole P., Rault D.: Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin.Infect.Dis.32, 897-928 (2000).
33. Petrovec M., Furlan S.L., Zupanc T.A., Strle F., Brouqui P., Roux V., Dumler J.S.: Human disease in Europe cause by a granulocytic Ehrlichia species. J.Clin.Microbiol.35, 1556-1559 (1997).
34. Ruscio M., Cinco M.: Human granulocytic ehrlichiosis in Italy: first report on two confirmed cases. Ann.N.Y.Acad.Sci.990, 350-352 (2003).
35. Schouls L., van De Pol I., Ripkema S.G., Schot C.S.: Detection and identification of Ehrlichia, Borrelia burgdorferi sensu lato and Bartonella species in Dutch Ixodes ricinus ticks. J.Clin.Microbiol.37, 2215-2222 (1999).
36. Sirigiredy K.R., Mock D.C., Ganta R.R.: Multiplex detection of Ehrlichia and Anaplasma pathogens in vertebrate and tick hosts by real-time rt-PCR. Ann.N.Y.Acad.Sci.1078, 552-556 (2006).
37. Steere A.C., McHugh G., Suarez C., Hoitt J., Damle N., Sikand V.K.: Prospective study of coinfection in patients with erythema migrans. Clin.Infect.Dis.36, 1078-1081 (2003).
38. Štefančíková A., Derdáková M., Lenčáková D., Ivanová R., Stanko M., Peťko B.: Serological and molecular detection of Borrelia burgdorferi sensu lato and Anaplasmataceae in rodents. Folia Microbiol.53, 493-499 (2008).
39. Strle F.: Human granulocytic ehrlichiosis in Europe. Internat.J.Microb.Med.7, 27-35 (2004).
40. Wilske B.: Diagnosis of Lyme borreliosis in Europe. Vector-Borne Zoon.Dis.3, 215-227 (2003).
41. Zeman P., Pazdiora P., Činátal J.: HGE antibodies in sera of patients with TBE in the Czech Republic. Internat.J.Microb.Med.291,191-193 (2002).